Imunon, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss
Imunon, Inc. (IMNN) had Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss of $10.16 thousand as of 2017-12-31, per its 10-K filed 2018-03-27.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss · last filed 2018-03-27
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $10.16K.
- 2016-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $479.00.
- 2015-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $3.86K.
- 2015-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $1.03K.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2017-12-31 | $10.16K 10-K · filed 2018-03-27 |
| 2016-09-30 | $479.00 10-Q · filed 2016-11-10 |
| 2015-12-31 | $3.86K 10-K · filed 2017-03-24 |
| 2015-09-30 | $1.03K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $2.54K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $7.95K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $16.03K 10-K · filed 2016-03-30 |
| 2014-09-30 | $26.07K 10-Q · filed 2014-11-10 |
| 2013-12-31 | $44.17K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |